A Major Milestone For Gene Editing To Treat Cancer- New Study Finds CRISPR Can Successfully Kill Cancer Cells Without an Adverse Affect on Patients

Updated February 9th, 2020

A Major Milestone For Gene Editing To Treat Cancer- New Study Finds CRISPR Can Successfully Kill Cancer Cells Without an Adverse Affect on Patients

Overseen by the renowned immunologist Dr. Carl June, it showed the edited genes had a sustained ability to attack and kill tumors.

NOW
PLAYING
A Significant Number of Cancer Patients are Lonely, New Research Suggests
NOW
PLAYING
If You're Over 65, Here's What You Need to Know About CAR T-Cell Therapy
NOW
PLAYING
New Hope For Stomach Cancer: Immunotherapy Drug Opdivo Now Approved As a First Treatment
NOW
PLAYING
What Should Blood Cancer Patients Do After They Get the COVID-19 Vaccine?
NOW
PLAYING
Which Vaccine is Best For Cancer Patients? 'The First One Available to You' Say Leading Experts
NOW
PLAYING
Some Melanoma Survivors See Long-Term Side Effects After Immunotherapy, Says New Study

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.